marches5 %The stock reacted positively, rising 5% during the session

Amoeba secures European market authorization

Amoeba announced it secured market authorization for its biocide in Europe.

Published 3sem1 sourceNotableupdated 5j

≈ 15sSpeed

The fact

This approval paves the way for commercialization in the EU starting in 2027.

The stock reacted positively, rising 5% during the session.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on July 1, 2026